LifeMD, Inc. is a publicly traded American telehealth company.
[4] The company was founded as ImmuDyne, Inc. in 1994 and completed its initial public offering in 2001.
[5] In 2018, it rebranded as Conversion Labs, Inc. with Justin Schreiber named chief executive officer.
[7][8] In June 2023, LifeMD announced a weight management program to prescribe GLP-1 medications upon meeting requirements in a virtual appointment with a clinician.
[9] It began a pilot program with Medifast, which later announced a partnership between the companies to connect each other's customers.